只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 2026-07-09 2026-07-13 | DNTH Dianthus Therapeutics, Inc. /DE/ | Savitz Ryan Officer · EVP, CFO & CBO | 卖出（S） | 5,566 | US$101.97 | US$567,565.02 | 0 | SEC |
| 2026-06-17 2026-06-18 | DNTH Dianthus Therapeutics, Inc. /DE/ | Veness Adam M Officer · SVP, General Counsel and Sec. | 卖出（S） | 13,229 | US$81.38 | US$107.66万 | 0 | SEC |
| 2026-06-17 2026-06-18 | DNTH Dianthus Therapeutics, Inc. /DE/ | Veness Adam M Officer · SVP, General Counsel and Sec. | 卖出（S） | 16,771 | US$80.34 | US$134.74万 | 13,229 | SEC |
| 2026-06-01 2026-06-02 | DNTH Dianthus Therapeutics, Inc. /DE/ | Randhawa Simrat Officer · EVP, Head of R&D | 卖出（S） | 16,943 | US$90.72 | US$153.71万 | 8,159 | SEC |
| 2026-06-01 2026-06-02 | DNTH Dianthus Therapeutics, Inc. /DE/ | Randhawa Simrat Officer · EVP, Head of R&D | 卖出（S） | 4,159 | US$91.37 | US$380,007.83 | 4,000 | SEC |
| 2026-06-01 2026-06-02 | DNTH Dianthus Therapeutics, Inc. /DE/ | Randhawa Simrat Officer · EVP, Head of R&D | 卖出（S） | 5,428 | US$89.72 | US$487,000.16 | 25,102 | SEC |
| 2026-05-08 2026-05-11 | DNTH Dianthus Therapeutics, Inc. /DE/ | Soteropoulos Paula Director | 卖出（S） | 599 | US$85.47 | US$51,196.53 | 0 | SEC |
| 2026-04-09 2026-04-10 | DNTH Dianthus Therapeutics, Inc. /DE/ | Savitz Ryan Officer · EVP, CFO & CBO | 卖出（S） | 8,224 | US$89.84 | US$738,844.16 | 0 | SEC |
| 2026-03-31 2026-04-01 | DNTH Dianthus Therapeutics, Inc. /DE/ | Soteropoulos Paula Director | 卖出（S） | 599 | US$80.11 | US$47,985.89 | 0 | SEC |
| 2026-03-31 2026-04-01 | DNTH Dianthus Therapeutics, Inc. /DE/ | Savitz Ryan Officer · EVP, CFO & CBO | 卖出（S） | 21,825 | US$78.86 | US$172.11万 | 91,152 | SEC |
| 2026-03-31 2026-04-01 | DNTH Dianthus Therapeutics, Inc. /DE/ | Savitz Ryan Officer · EVP, CFO & CBO | 卖出（S） | 1,485 | US$80.25 | US$119,171.25 | 89,667 | SEC |
| 2026-03-31 2026-04-01 | DNTH Dianthus Therapeutics, Inc. /DE/ | Savitz Ryan Officer · EVP, CFO & CBO | 卖出（S） | 800 | US$81.36 | US$65,088.00 | 88,867 | SEC |
| 2026-03-31 2026-04-01 | DNTH Dianthus Therapeutics, Inc. /DE/ | Savitz Ryan Officer · EVP, CFO & CBO | 卖出（S） | 2,366 | US$82.84 | US$195,999.44 | 86,501 | SEC |
| 2026-03-31 2026-04-01 | DNTH Dianthus Therapeutics, Inc. /DE/ | Savitz Ryan Officer · EVP, CFO & CBO | 卖出（S） | 59,800 | US$83.90 | US$501.72万 | 26,701 | SEC |
| 2026-03-31 2026-04-01 | DNTH Dianthus Therapeutics, Inc. /DE/ | Savitz Ryan Officer · EVP, CFO & CBO | 卖出（S） | 19,469 | US$84.57 | US$164.65万 | 7,232 | SEC |
| 2026-03-31 2026-04-01 | DNTH Dianthus Therapeutics, Inc. /DE/ | Savitz Ryan Officer · EVP, CFO & CBO | 卖出（S） | 7,232 | US$85.54 | US$618,625.28 | 0 | SEC |
| 2026-03-31 2026-04-01 | DNTH Dianthus Therapeutics, Inc. /DE/ | Savitz Ryan Officer · EVP, CFO & CBO | 卖出（S） | 1,390 | US$78.33 | US$108,878.70 | 112,977 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| DNTH | 207,152.2742 | 0 | 301,060.8811 | 68.81% | B, Q, N |